AI and the Evolving Landscape of Digital Pathology

In the era of artificial intelligence (AI), an ideal digital pathology platform must provide both choice and flexibility. Before the advent of AI, the landscape of pathology was already rapidly evolving, with many different digital pathology platforms and providers, each with their own requirements, shortcomings, and benefits. The recent development and advancement of AI has only made the platform selection process more complex. In addition to each vendor offering a different selection of tools to choose from, many AI and image analysis tools cannot be used as standalone products and require a digital pathology platform to act as the interface between the algorithm and the pathologist. Platforms that enable integration with a users’ solutions and equipment of choice support the creation of a customized digital pathology ecosystem, one that allows for increased workflow efficiency, collaboration, and adaptation to the unique needs of the individual practice. By supporting this degree of customization, highly adaptable digital pathology platforms, like HALO AP® from Indica Labs, help labs create individualized digital pathology workflows while simultaneously enabling laboratories to keep up-to-date on the latest advancements.

The Need for a Flexible, Highly Integrated Digital Pathology Platform and the Importance of Open Pathology

Users of digital pathology platforms that do not easily integrate with third-party AI and image analysis tools are at a large disadvantage and can become “locked-in” to their solution provider, preventing them from staying at the forefront of technological advancement and from creating their optimal digital pathology ecosystem. This severely limits their ability to realize all the benefits of digital pathology. As advanced AI and image analysis tools continue to develop and be adopted, it becomes increasingly important that digital pathology platforms offer a high degree of flexibility and adaptability. The best digital pathology platform is easy-to-use while being powerful enough to integrate with the widest variety of tools, solutions, LIS | LIMS, and other laboratory equipment possible.

Pathology is tasked with providing timely and accurate diagnoses to patients and with generating the information used to guide their prognostication and treatment. With so much at stake, there is little room for being locked into a system that does not provide the tools needed to perform the job. Providing users with the freedom to implement their AI algorithms of choice, as well as the ability to integrate with other laboratory equipment and tools, is paramount to establishing truly open pathology.

HALO AP: The Solution for Integrated Pathology Labs and Practices

HALO AP® offers pathology labs and practices an optimal solution to these challenges, empowering them with freedom of choice to select any AI algorithm that meets their needs. Through a commitment to open pathology, ease-of-use, and patient care, HALO AP provides a superior software ecosystem for modern pathology labs and those looking ahead. Indica Labs has been dedicated to this principle from its inception and created HALO AP with an understanding of the importance of the work being done every day by pathologists and researchers in the clinical space. By prioritizing user collaboration, maintaining a flexible and powerful integration engine, and providing excellent customer support, Indica Labs offers a complete diagnostic digital pathology solution with HALO AP.

HALO AP, with its broad range of ready-to-use AI tools, wide selection of third-party integrations like DeepBio, Ibex, and Lunit, and powerful integration engine, empowers labs ready to upgrade to AI-driven pathology with the versatility they need. While Indica Labs HALO Clinical AI offers users algorithms for applications spanning quality control, cancer detection and grading, and IHC expression analysis, HALO AP is also able to integrate with any third-party AI or image analysis algorithm and present the results in the native interface, eliminating the need to navigate between systems. Users are provided with the solid foundation of annotation, collaboration, and reporting tools they need to conduct efficient diagnostic evaluations and can feel confident that they’ll be prepared to adapt to both their changing needs and to future technologic advancements. To learn more about HALO AP, HALO Clinical AI Solutions, or third-party integrations in HALO AP, please contact info@indicalab.com.  

_{HALO AP® is CE-IVDR marked for in-vitro diagnostic use in Europe, the UK, and Switzerland. HALO AP is For Research Use Only in the US and is not FDA cleared for clinical diagnostic use. In addition, HALO AP provides built-in compliance and certifications with FDA 21 CFR Part 11, ISO 13485:2016, HIPAA, and GDPR.}

_{HALO AI Prostate is CE-marked for in-vitro diagnostic use in Europe, the UK, and Switzerland. HALO AI Prostate is For Research Use Only in the US and is not FDA cleared for clinical diagnostic use. HALO AI Prostate is accessed via the HALO AP® enterprise digital pathology platform.}

_{Lung PD-L1 AI is For Research Use Only and not intended for clinical diagnostic use. Lung PD-L1 AI is accessed via the HALO AP® enterprise digital pathology platform.}

_{Breast IHC AI is For Research Use Only and not intended for clinical diagnostic use. Breast IHC AI is accessed via the HALO AP® enterprise digital pathology platform.}

_{SlideQC BF is a quality control tool for whole slide images and is not regulated as a medical device under Regulation EU 2017/746 (IVDR) or MDR 2002 (UK).}

_{Lung Macrodissect AI is For Research Use Only and not intended for clinical diagnostic use. Lung Macrodissect AI is accessed via the HALO AP® enterprise digital pathology platform.}